BRITTANY HURST: Open Payments
NPI 1720843212 · SILVERDALE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,805 in 59 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $494 · 2025 $1,805
Food & beverage: $1,805
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $524 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $258 |
| Janssen Biotech, Inc. | 9 | $236 |
| Madrigal Pharmaceuticals | 3 | $126 |
| Phathom Pharmaceuticals, Inc. | 3 | $125 |
| Gilead Sciences, Inc. | 1 | $101 |
| Aimmune Therapeutics, Inc. | 4 | $96 |
| PFIZER INC. | 5 | $80 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $69 |
| QOL Medical, LLC | 2 | $46 |
Products named: TREMFYA, SKYRIZI, ENTYVIO, RINVOQ, REZDIFFRA, VOQUEZNA, MAVYRET, Livdelzi.
Industry payments across WA — which companies pay providers there.
